Crowdonomics
PhorMed

Reg CF · Common Stock · Oct 2023

ClosedReg CFCommon Equity
via DealMaker · last checked Sep 23, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Estimated pre-money
$52.5M
—

Financials disclosed in this offering

FY2021–FY2022 · hover for source
$0
−$574K
FY2021
$0
−$1.5M
FY2022
RevenueNet income
Metric
FY2021 audited
FY2022 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$573,584
-$1,477,413
Taxes paid
$0
$0
Balance sheet
Cash
$105,694
$171,333
Accounts receivable
$0
$0
Total assets
$183,724
$746,059
Short-term debt
$227,264
$714,494
Long-term debt
$0
$0
Total liabilities
$227,264
$714,494
Other
Headcount
6
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Apr 24, 2025
    • Deadline Apr 30, 2025 → Apr 30, 2026

    “Adding 2024 financials and extending campaign.”

    Form C/A on EDGAR ↗
  2. Apr 24, 2024
    • Deadline Apr 29, 2024 → Apr 30, 2025

    “Adding 2023 financials and extending campaign.”

    Form C/A on EDGAR ↗
  3. Dec 15, 2023
    • Deadline Jan 31, 2024 → Apr 29, 2024
    • Target $10K → $50K

    “Switching to a different intermediary.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Est. pre-money$52.5M
Price / share$1.00
Shares offered10,000

Estimated, not stated: $1.00 × 52,523,767 securities outstanding as of Dec 31, 2022 (Form C-AR filed Apr 26, 2024, p. 5).

Offering details

Target$10,000
Max$5,000,000
Min investment—
OpenedOct 27, 2023
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active916

Links & provenance

Source: SEC EDGAR
0001662252-23-000025
Last synced Sep 23, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.